Cargando…

Biliary Involvement in Type 2 Autoimmune Pancreatitis

Autoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollo, Diana, Terraz, Sylvain, Arnoux, Gregoire, Puppa, Giacomo, Frossard, Jean-Louis, Bichard, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514518/
https://www.ncbi.nlm.nih.gov/pubmed/31123447
http://dx.doi.org/10.1159/000499422
_version_ 1783417888142524416
author Ollo, Diana
Terraz, Sylvain
Arnoux, Gregoire
Puppa, Giacomo
Frossard, Jean-Louis
Bichard, Philippe
author_facet Ollo, Diana
Terraz, Sylvain
Arnoux, Gregoire
Puppa, Giacomo
Frossard, Jean-Louis
Bichard, Philippe
author_sort Ollo, Diana
collection PubMed
description Autoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasmocytes. In this condition, hepatobiliary infiltration is frequent and often mimics cholangiocarcinoma or primary sclerosing cholangitis. On the other hand, type 2 is commonly limited to the pancreas. Herein, we describe the case of a patient who presented a type 2 AIP associated with cholangiopathy, a condition not described in the established criteria. He first developed a pancreatitis identified as type 2 by the typical histopathological features and lack of IgG4 in the serum and tissue. Despite a good clinical response to steroids, cholestasis persisted, identified by MR cholangiography as a stricture of the left hepatic duct with dilatation of the intrahepatic bile duct in segments 2 and 3. Biliary cytology was negative. Evolution was favorable but after steroid tapering a few months later, the patient suffered from recurrence of the pancreatitis as well as progression of biliary attempt, suspicious for cholangiocarcinoma. As the investigations again ruled out neoplastic infiltration or primary sclerosing cholangitis, azathioprine was initiated with resolution of both pancreatic and biliary attempts.
format Online
Article
Text
id pubmed-6514518
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-65145182019-05-23 Biliary Involvement in Type 2 Autoimmune Pancreatitis Ollo, Diana Terraz, Sylvain Arnoux, Gregoire Puppa, Giacomo Frossard, Jean-Louis Bichard, Philippe Case Rep Gastroenterol Single Case Autoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasmocytes. In this condition, hepatobiliary infiltration is frequent and often mimics cholangiocarcinoma or primary sclerosing cholangitis. On the other hand, type 2 is commonly limited to the pancreas. Herein, we describe the case of a patient who presented a type 2 AIP associated with cholangiopathy, a condition not described in the established criteria. He first developed a pancreatitis identified as type 2 by the typical histopathological features and lack of IgG4 in the serum and tissue. Despite a good clinical response to steroids, cholestasis persisted, identified by MR cholangiography as a stricture of the left hepatic duct with dilatation of the intrahepatic bile duct in segments 2 and 3. Biliary cytology was negative. Evolution was favorable but after steroid tapering a few months later, the patient suffered from recurrence of the pancreatitis as well as progression of biliary attempt, suspicious for cholangiocarcinoma. As the investigations again ruled out neoplastic infiltration or primary sclerosing cholangitis, azathioprine was initiated with resolution of both pancreatic and biliary attempts. S. Karger AG 2019-04-12 /pmc/articles/PMC6514518/ /pubmed/31123447 http://dx.doi.org/10.1159/000499422 Text en Copyright © 2019 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Ollo, Diana
Terraz, Sylvain
Arnoux, Gregoire
Puppa, Giacomo
Frossard, Jean-Louis
Bichard, Philippe
Biliary Involvement in Type 2 Autoimmune Pancreatitis
title Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_full Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_fullStr Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_full_unstemmed Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_short Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_sort biliary involvement in type 2 autoimmune pancreatitis
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514518/
https://www.ncbi.nlm.nih.gov/pubmed/31123447
http://dx.doi.org/10.1159/000499422
work_keys_str_mv AT ollodiana biliaryinvolvementintype2autoimmunepancreatitis
AT terrazsylvain biliaryinvolvementintype2autoimmunepancreatitis
AT arnouxgregoire biliaryinvolvementintype2autoimmunepancreatitis
AT puppagiacomo biliaryinvolvementintype2autoimmunepancreatitis
AT frossardjeanlouis biliaryinvolvementintype2autoimmunepancreatitis
AT bichardphilippe biliaryinvolvementintype2autoimmunepancreatitis